A PIPELINE POWERED BYPASSION
PUBLICATIONS AND PRESENTATIONS
The Effect of the Cardiac Myosin Activator, Omecamtiv Mecarbil, on Diastolic Filling and Function in Chronic Systolic Heart Failure (COSMIC-HF)
American Heart Association Scientific Session 2019
Philadelphia, PA
November 18, 2019
FORTITUDE-ALS: Who Received the Most Benefit, and Translation to Real-World Events
Poster, 18th Annual NEALS Meeting
Clearwater Beach, FL
October 3, 2019
Multicenter Exercise Tolerance Evaluation of Omecamtiv Mecarbil Related to Increased Contractility in Heart Failure (METEORIC-HF)
Poster, Heart Failure Society of America (HFSA) 2019 Scientific Meeting
Philadelphia, PA
September 14, 2019
A First-in-Human Study of the Selective Cardiac Myosin Inhibitor, CK-3773274
Poster, Heart Failure Society of America (HFSA) 2019 Scientific Meeting
Philadelphia, PA
September 14, 2019
The Cardiac Myosin Inhibitor, CK-3773274, Reduces Contractility in the R403Q Mouse Model of Hypertrophic Cardiomyopathy
Poster, American Heart Association Basic Cardiovascular Sciences (BCVS) 2019 Scientific Sessions
Boston, MA
July 30, 2019